Propensity Scoring and Beyond: Why? and How? Midwest Biopharmaceutical Statistics Workshop, 2009.

Slides:



Advertisements
Similar presentations
June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.
Advertisements

Estimating a causal effect using observational data Aad van der Vaart Afdeling Wiskunde, Vrije Universiteit Amsterdam Joint with Jamie Robins, Judith Lok,
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Observational Studies Based on Rosenbaum (2002) David Madigan Rosenbaum, P.R. (2002). Observational Studies (2 nd edition). Springer.
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Can we prevent stent restenosis after coronary stent implantation
Confounding And Interaction Dr. L. Jeyaseelan Department Of Biostatistics CMC, Vellore.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
Sample Size Determination
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Brar et al, JACC 2011 Impact of Platelet Reactivity When On-treatment With Clopidogrel on Mortality, MI or Stent Thrombosis After PCI Impact of Platelet.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Advanced Statistics for Interventional Cardiologists.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Lecture 8: Generalized Linear Models for Longitudinal Data.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Article Review Cara Carty 09-Mar-06. “Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of.
Weaknesses of major randomized trials: they are cleverly designed against coronary surgery. They are not representative of the daily practice (highly selected.
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
Long Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts Laura Mauri, MD, MSc; Treacy Silverstein, B.Sc.; Ann Lovett,
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Maurizio Menichelli MD San Camillo Hospital, Rome ( SESAMI Trial) Maurizio Menichelli Presenter Disclosure Information Nothing to Disclose Randomized trial.
Lecture 12: Cox Proportional Hazards Model
A generalized bivariate Bernoulli model with covariate dependence Fan Zhang.
Samsung Medical Center Cardiac & Vascular Center Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Myung-Ho Jeong, Hyo-Soo Kim,
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Using Propensity Score Matching in Observational Services Research Neal Wallace, Ph.D. Portland State University February
1 Hester van Eeren Erasmus Medical Centre, Rotterdam Halsteren, August 23, 2010.
All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.
Local Control Bob Obenchain, PhD, FASA Risk Benefit Statistics LLC Yin = Dark = Evil = Risk Yang = Light = Good = Benefit.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
1 Statistical Review of the Observational Studies of Aprotinin Safety Part II: The i3 Drug Safety Study CRDAC and DSaRM Meeting September 12, 2007 P. Chris.
Confounding adjustment: Ideas in Action -a case study Xiaochun Li, Ph.D. Associate Professor Division of Biostatistics Indiana University School of Medicine.
Transparency in the Use of Propensity Score Methods
Life expectancy Stuart Harris Public Health Intelligence Analyst Course – Day 3.
(ARM 2004) 1 INNOVATIVE STATISTICAL APPROACHES IN HSR: BAYESIAN, MULTIPLE INFORMANTS, & PROPENSITY SCORES Thomas R. Belin, UCLA.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of 1-Year Mortality in Patients With Acute.
Matching methods for estimating causal effects Danilo Fusco Rome, October 15, 2012.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Addressing Confounding in Real-World Evidence Using Propensity Scores
The Association between Prehospital Time Intervals and ST-Elevation Myocardial Infarction System Performance.
Long-Term Forecasting and Comparison of Mortality in the Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness.
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
Catheter-Based Treatment of Coronary Artery Disease
Presenter: Wen-Ching Lan Date: 2018/03/28
National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered.
Giuseppe Biondi Zoccai, MD
American Heart Association Presented by Dr. Julinda Mehilli
STENT THROMBISIS Insights on Outcomes and Impact of DUAL ANTIPLATELET THERAPY Permanent Discontinuation SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE.
Predicted and observed HbA1c levels using doubly robust estimation adjusting for either a comprehensive set of confounders (left panel) or a set of confounders.
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
No Financial Disclosure or Conflict of Interest
Trichopoulou A, et al. BMJ 2009;338:b2337
Flow Diagram of the Trial Selection Process
Predicted and observed BMI levels using doubly robust estimation adjusting for either a comprehensive set of confounders (left panel) or a set of confounders.
Forest plots of randomised controlled trials and propensity score matched studies examining outcomes between patients taking proton pump inhibitor (PPIs)
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
A: Probability of SICH by baseline glucose level.
Presentation transcript:

Propensity Scoring and Beyond: Why? and How? Midwest Biopharmaceutical Statistics Workshop, 2009

Notation for Variables y = observed outcome variable(s) x = observed baseline covariate(s) t = observed treatment assignment (usually non-random) z = unobserved explanatory variable(s)

Confounding A fundamental difficulty in observational research is that the probability of treatment assignment, t, is NOT independent of the observed baseline x-covariates. Moreover, these baseline x-covariates are often not ignorable/ancillary. They may of themselves be predictive of y-outcome.

Propensity Score “Factoring” Joint distribution of x and t given p: Pr( x, t | p ) = Pr( x | p ) Pr( t | p ) i.e. x and t are conditionally independent given the propensity for “new” treatment, p = Pr( t = 1 | x ).

Why Go Beyond PS Methods? 1.True PS frequently UNKNOWN. 2.Estimated PS can easily fail to function the same as true PS. 3.Validating PS Estimates can be Tedious and Frustrating. 4.Alternatives are worth exploring!

Numerical Example for this Session. The data in the freely distributed “analytical files,” Lsim10K and Lsim5K, used in this session were simulated to be “like” that in an actual OS with only ~1K patients (Lindner Center: Kereiakes et al. Amer Heart J ) Unfortunately, many authors and study sponsors do not recognize that sharing their data enhances the credibility of both their study and their analyzes!

The “LSIM10K” dataset contains 10 simulated measurements on 10,325 hypothetical patients. [1] mort6mo : Binary 6-month mortality indicator. [2] cardcost : Cumulative 6-month cardiac related charges. [3] trtm : Binary indicator (1 => treated, 0 => untreated). [4] stent : Binary indicator (1 => coronary stent deployment.) [5] height : Patient height rounded to the nearest centimeter. [6] female : Binary sex indicator (1 => yes, 0 => male.) [7] diabetic : Binary indicator (1 => diabetes mellitus, 0 => no.) [8] acutemi : Binary indicator (1 => acute myocardial infarction within the previous 7 days, 0 => no.) [9] ejecfrac : Left ejection fraction % rounded to integer. [10] ves1proc : Number of vessels involved in initial PCI.

Confounding adjustment: concepts and heuristic ideas. Lingling Li, Harvard Medical School and Harvard Pilgrim Health Care Confounding adjustment: ideas in action – a case study. Xiaochun Li, Div. Biostatistics, IU School of Medicine BREAK The “Local Control” Approach. Bob Obenchain, Risk Benefit Statistics LLC DISCUSSION Gerhardt Pohl, Research Advisor, Lilly USA